TOVX · Theriva Biologics, Inc.

Summary

Theriva Biologics, Inc. filed a Form 8-K on March 12, 2026, under Item 2.02 disclosing results of operations via a press release attached as Exhibit 99.1. Item 9.01 lists the exhibits including the press release and Cover Page Interactive Data File (104).

Key takeaways

• Form 8-K filed on 2026-03-12
• Item 2.02 - Results of Operations disclosed
• Exhibit 99.1 - Press Release dated March 12, 2026
• Exhibit 104 - Cover Page Interactive Data File